Insmed | INSM - Trade Debtors

Stock Price
153.02
Daily Change
1.99 1.32%
Monthly
-13.06%
Yearly
91.39%
Q1 Forecast
152.04

Insmed reported $65.26M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
BioMarin Pharmaceutical USD 790.27M 65.59M Sep/2025
Cytokinetics USD 1.81M 6.6M Sep/2025
DBV Technologies USD 15.97M 279K Sep/2025
Dynavax Technologies USD 73.34M 16.79M Jun/2025
Gilead Sciences USD 5.1B 314M Sep/2025
Insmed USD 65.26M 10.23M Sep/2025
Novartis USD 8.98B 192M Sep/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Sarepta Therapeutics USD 395.74M 213.86M Sep/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
Vertex Pharmaceuticals USD 1.95B 52.9M Sep/2025